Keywords: Youth treatment, Diabetes, Metformin, Rosiglitazone, Avandia

Two drugs better than one to treat youth with type 2 diabetes

Article | 30 April 2012

Print This

A combination of two diabetes drugs, metformin and rosiglitazone (the active ingredient of GlaxoSmithKline’s Avandia, now virtually withdrawn ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in